This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: University of Leeds. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Sin Ying Cheung: Innovator in TRPC Ion Channel Inhibitors
Introduction
Sin Ying Cheung is a prominent inventor based in Stanford, CA. She has made significant contributions to the field of medical therapy through her innovative research. Her work primarily focuses on the development of inhibitors for Transient Receptor Potential Canonical (TRPC) ion channels.
Latest Patents
Sin Ying Cheung holds a patent for "TRPC ion channel inhibitors for use in therapy." This patent describes inhibitors that target TRPC4 and TRPC5 proteins. These inhibitors are designed to combat obesity and other medical conditions, including insulin resistance associated with Type II diabetes, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). Additionally, the patent discloses the use of these inhibitors for cosmetic purposes, such as cosmetic weight loss. She has 1 patent to her name.
Career Highlights
Sin Ying Cheung is affiliated with the University of Leeds, where she continues her research and development efforts. Her work has garnered attention for its potential impact on public health and wellness.
Collaborations
Some of her notable coworkers include Richard James Foster and David John Beech. Their collaborative efforts contribute to the advancement of research in the field of ion channel inhibitors.
Conclusion
Sin Ying Cheung is a trailblazer in the development of TRPC ion channel inhibitors, with a focus on addressing significant health issues. Her innovative work holds promise for both therapeutic and cosmetic applications.